In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results